Free Online CME

≡ Menu



Primary Vasculitides:
Best Practices and Future Advances
Online Monograph

Print this Content

Release Date:  August 23, 2017
Expiration Date:   August 23, 2019

Estimated Time of Completion:  1 hour

Description

The Primary Vasculitides: Best Practices and Future Advances Online Monograph features abstracts written by multi-disciplinary faculty of experts critically appraising recent basic laboratory breakthroughs in terms of their potential clinical implications and providing in-depth analyses of approved agents, new agents, predicting toxicity, clinical controversies, and new indications.

Learning Objectives

  1. Recognize the signs and symptoms of systemic vasculitic diseases in patients presenting with immunologic-associated conditions.
  2. Summarize efficacy and side effect data on use of conventional immunosuppressive agents to treat systemic vasculitis.
  3. Critically appraise the efficacy and side effect profiles, indications, and patient selection criteria for biologics in patients with systemic vasculitis.
  4. Provide an analytical review of the presentation, diagnosis, and treatment of CNS vasculitis.

Target Audience

This online monograph is directed towards rheumatologists, nephrologists, pulmonologists, dermatologists, neurologists, allergists, immunologists, and advanced practice clinicians interested in vasculitis.

Accreditation

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

Activity Directors and Faculty

Activity Directors

Leonard Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
R.J. Fasenmyer Chair of Clinical Immunology
Theodore F. Classen DO Chair of Osteopathic Research and Education
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Rula Hajj-Ali, MD
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Associate Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Carol Langford, MD, MHS
Harold C. Schott Endowed Chair in Rheumatic and Immunologic Diseases
Director, Center for Vasculitis Care and Research
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Faculty

Tiffany Clark, MSN, CNP
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Anthony Fernandez, MD, PhD
Department of Dermatology
Department of Anatomic Pathology
Dermatology and Plastic Surgery Institute
Cleveland Clinic
Cleveland, OH

Ulrich Specks, MD
Professor of Medicine
Chair, Pulmonary and Critical Care Medicine
Mayo Clinic
Rochester, MN

W.H. Wilson Tang, MD
Department of Cardiovascular Medicine
Heart and Vascular Institute
Cleveland Clinic
Cleveland, OH

Alexandra Villa-Forte, MD, MPH
Department of Rheumatic and Immunologic Diseases
Orthopaedic and Rheumatologic Institute
Cleveland Clinic
Cleveland, OH

Kenneth J. Warrington, MD
Chair, Division of Rheumatology
Professor of Medicine
Mayo Clinic College of Medicine
Rochester, MN

Michael E. Wechsler, MD, MMSc
Professor of Medicine
Director, Asthma Program
Department of Medicine
National Jewish Health
Denver, CO

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that they may have a relationship, which in the context of their presentation, could be perceived as a potential conflict of interest:

Leonard Calabrese, DO
  Abbvie, Inc.; Bristol-Myers Squibb; Genentech/Roche; Janssen Consulting; Teaching and Speaking
  GlaxoSmithKline; Pfizer, Inc.; UCB Consulting
  Crescendo Teaching and Speaking
 
Anthony Fernandez, MD, PhD
  AbbVie Pharmaceuticals Independent contractor (including contracted research)
Teaching and Speaking
  Celgene Corporation Teaching and Speaking
  Mallinckrodt Inc. Independent contractor (including contracted research)
  Novartis Consulting
  Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
 
Carol Langford, MD, MHS
  Bristol-Myers Squibb Co., Genentech, GlaxoSmithKline Clinical trial funding support
 
Kenneth J. Warrington, MD
  GlaxoSmithKline Independent contractor (including contracted research)
 
Michael E. Wechsler, MD, MMSc
  AstraZeneca Pharmaceuticals Consulting; Teaching and Speaking
  Genentech, Glaukos Corporation, Novartis, Regeneron,
Sanofi, Teva, Vital Health Interventions
Consulting
  GlaxoSmithKline Consulting;
Membership on advisory committee or review panels

The following faculty have indicated that they have no relationship which, in the context of their presentation, could be perceived as a potential conflict of interest:

Tiffany Clark, MSN, CNP
Rula Hajj-Ali, MD
Ulrich Specks, MD
W.H. Wilson Tang, MD
Alexandra Villa-Forte, MD, MPH

The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of this activity from:

Genentech
Vasculitis Foundation

This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education and
R.J. Fasenmyer Center for Clinical Immunology
.